Compare Lumentum (LITE) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lumentum vs State Street SPDR S&P Biotech ETF — how do they compare? Lumentum trades at $1,115.27 (market cap $94.99B), while State Street SPDR S&P Biotech ETF trades at $153.99 (market cap $10.11B). The key difference: Lumentum is far larger — about 9.4× State Street SPDR S&P Biotech ETF's market cap, and State Street SPDR S&P Biotech ETF is more actively traded (12,903,266 versus 4,855,776). Which is the better fit depends on your goals — on Pluang, investors hold Lumentum for 4 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| LITE | XBI | |
|---|---|---|
Market Cap | $94.99B | $10.11B |
Volume | 4,855,776 | 12,903,266 |
Sector | Technology | Broad Market / Factor |
52-Week High | $1.13K | $169.55 |
52-Week Low | $149.61 | $104.99 |
Typical Hold Time | 4 Days | 38 Days |
Enterprise Value | $93.92B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $153.84, up 2.4% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure offers broad biotech exposure, benefiting from M&A activity and positive clinical catalysts, though key financial ratios are unavailable. Recent news highlights sector optimism driven by cancer vaccine breakthroughs and improved capital access.
Outlook is mixed: bullish sentiment from innovation and M&A supports growth potential, but high volatility and expense ratios relative to peers pose risks. Analyst consensus is neutral (100% Hold), suggesting cautious optimism amid technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lumentum
Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.
Read more on LITE →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
